Rituximab
CSPC-DED-DLBCL-K08
Phase 3 small_molecule active
Quick answer
Rituximab for Diffuse Large B-cell Lymphoma is a Phase 3 program (small_molecule) at First Tracks Biotherapeutics with 3 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Diffuse Large B-cell Lymphoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active